000764535 000__ 01555cam\a2200421M\\4500
000764535 001__ 764535
000764535 005__ 20230306142421.0
000764535 006__ m\\\\\o\\d\\\\\\\\
000764535 007__ cr\un\nnnunnun
000764535 008__ 161130s2016\\\\sz\\\\\\o\\\\\000\0\eng\d
000764535 019__ $$a964933039
000764535 020__ $$a9783319465050$$q(electronic book)
000764535 020__ $$a3319465058$$q(electronic book)
000764535 020__ $$z9783319465043
000764535 020__ $$z331946504X
000764535 035__ $$aSP(OCoLC)ocn964643905
000764535 035__ $$aSP(OCoLC)964643905$$z(OCoLC)964933039
000764535 040__ $$aYDX$$beng$$cYDX$$dN$T$$dEBLCP$$dIDEBK$$dGW5XE$$dN$T
000764535 049__ $$aISEA
000764535 050_4 $$aRC280.B7
000764535 08204 $$a616.99/48106$$223
000764535 24500 $$aResistance to targeted therapies against adult brain cancers$$h[electronic resource] /$$cAmanda Tivnan, editor.
000764535 260__ $$aCham, Switzerland :$$bSpringer,$$c2016.
000764535 300__ $$a1 online resource.
000764535 336__ $$atext$$btxt$$2rdacontent
000764535 337__ $$acomputer$$bc$$2rdamedia
000764535 338__ $$aonline resource$$bcr$$2rdacarrier
000764535 4901_ $$aResistance to targeted anti-cancer therapeutics,$$x2196-5501 ;$$vv. 11
000764535 506__ $$aAccess limited to authorized users.
000764535 650_0 $$aBrain$$xCancer$$xTreatment.
000764535 650_0 $$aDrug resistance in cancer cells.
000764535 7001_ $$aTivnan, Amanda,$$eeditor.
000764535 77608 $$iPrint version:$$z9783319465043$$z331946504X$$w(OCoLC)957140773
000764535 830_0 $$aResistance to targeted anti-cancer therapeutics ;$$vv. 11.
000764535 852__ $$bebk
000764535 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-46505-0$$zOnline Access$$91397441.1
000764535 909CO $$ooai:library.usi.edu:764535$$pGLOBAL_SET
000764535 980__ $$aEBOOK
000764535 980__ $$aBIB
000764535 982__ $$aEbook
000764535 983__ $$aOnline
000764535 994__ $$a92$$bISE